<?xml version="1.0" encoding="UTF-8"?>
<p id="Par38">In addition to its sensitivity, NAT has the advantage that new tests can be developed relatively rapidly, as it is not necessary to develop and qualify antibodies or other rare reagents. Once testing platforms are available, they can readily accept newly developed tests. These factors contributed to the rapid adoption of tests for WNV and Zika virus in the United States. However, they are not necessarily appropriate for many parts of the developing world.</p>
